AU2023233349A1 - Glucuronidase activator, pharmaceutical composition, edible composition, and composition for oral application - Google Patents

Glucuronidase activator, pharmaceutical composition, edible composition, and composition for oral application Download PDF

Info

Publication number
AU2023233349A1
AU2023233349A1 AU2023233349A AU2023233349A AU2023233349A1 AU 2023233349 A1 AU2023233349 A1 AU 2023233349A1 AU 2023233349 A AU2023233349 A AU 2023233349A AU 2023233349 A AU2023233349 A AU 2023233349A AU 2023233349 A1 AU2023233349 A1 AU 2023233349A1
Authority
AU
Australia
Prior art keywords
glucuronidase
activator
strain
lactic acid
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU2023233349A
Other languages
English (en)
Inventor
Shinichi Honda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kaneka Corp
Original Assignee
Kaneka Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kaneka Corp filed Critical Kaneka Corp
Publication of AU2023233349A1 publication Critical patent/AU2023233349A1/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/41—Pediococcus
    • A23V2400/413—Acidilactici
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Endocrinology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Diabetes (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Reproductive Health (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
AU2023233349A 2022-03-17 2023-03-14 Glucuronidase activator, pharmaceutical composition, edible composition, and composition for oral application Pending AU2023233349A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2022042917 2022-03-17
JP2022-042917 2022-03-17
PCT/JP2023/009929 WO2023176849A1 (ja) 2022-03-17 2023-03-14 グルクロニダーゼ活性剤、医薬組成物、食用組成物、及び経口用組成物

Publications (1)

Publication Number Publication Date
AU2023233349A1 true AU2023233349A1 (en) 2024-10-10

Family

ID=88023802

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2023233349A Pending AU2023233349A1 (en) 2022-03-17 2023-03-14 Glucuronidase activator, pharmaceutical composition, edible composition, and composition for oral application

Country Status (7)

Country Link
EP (1) EP4509129A4 (https=)
JP (1) JPWO2023176849A1 (https=)
KR (1) KR20250006837A (https=)
CN (1) CN119013031A (https=)
AU (1) AU2023233349A1 (https=)
MX (1) MX2024011198A (https=)
WO (1) WO2023176849A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025231132A1 (en) * 2024-04-30 2025-11-06 Kaneka Americas Holding, Inc. Probiotic strain for weight management
CN118726138B (zh) * 2024-06-06 2025-04-04 福建中益制药有限公司 一种短促生乳杆菌及其应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6041125U (ja) 1983-08-29 1985-03-23 富士ロビン株式会社 背負式刈払機の伝動部におけるフレキシブル伝動軸の取付構造
JP4627555B2 (ja) 2008-08-07 2011-02-09 本田技研工業株式会社 車体構造
CN102905712B (zh) 2010-01-28 2015-12-16 Ab－生物学有限公司 用于治疗肠炎的益生菌组合物
EP2420580A1 (en) 2010-08-18 2012-02-22 AB-Biotics, S.A. Probiotic composition for oral health
JP6041125B2 (ja) 2012-07-06 2016-12-07 株式会社あすか製薬メディカル エストロゲンの超高感度測定法
EA201990630A1 (ru) * 2016-10-03 2019-10-31 Устойчивые к антисептику молочнокислые бактерии
KR102107443B1 (ko) * 2018-08-31 2020-05-07 (주)바이오리듬 여성 갱년기 증상 예방 또는 치료용 유산균 프로바이오틱스 제제
JP7604168B2 (ja) 2020-09-03 2024-12-23 ブラザー工業株式会社 画像形成方法および画像形成装置
CN113249256B (zh) * 2021-05-18 2023-04-28 江南大学 一株缓解雌激素相关代谢紊乱及肥胖的植物乳杆菌及应用

Also Published As

Publication number Publication date
MX2024011198A (es) 2024-11-08
CN119013031A (zh) 2024-11-22
WO2023176849A1 (ja) 2023-09-21
KR20250006837A (ko) 2025-01-13
EP4509129A4 (en) 2026-03-04
EP4509129A1 (en) 2025-02-19
JPWO2023176849A1 (https=) 2023-09-21

Similar Documents

Publication Publication Date Title
US11447740B2 (en) Lactic acid bacterium and use thereof
US10293004B2 (en) Butyrate-producing bacterium and use thereof
US10405569B2 (en) Lanctobacillus plantarum HAC01 strain having anti-inflammatory efficacy and metabolic disease alleviating efficacy and use thereof
US12152232B2 (en) Lactobacillus paracasei strain
KR100686557B1 (ko) 체지방 저하 기능성 락토바실러스 람노서스와 이를 함유한 식품
EP2634269A1 (en) New strain of lactic acid bacteria and its combinations producing probiotic preparations
EP3483281A1 (en) Extracellular polysaccharide of lactic acid bacteria and use thereof
AU2021242110A1 (en) Lactobacillus delbrueckii subsp. lactis CKDB001 strain, and composition for prevention, amelioration, or treatment of non-alcoholic fatty liver comprising same
Ding et al. Autochthonous Bacillus subtilis and Enterococcus faecalis improved liver health, immune response, mucosal microbiota and red-head disease resistance of yellow drum (Nibea albiflora)
EP4509129A1 (en) Glucuronidase activator, pharmaceutical composition, edible composition, and composition for oral application
KR20180044245A (ko) 변비 개선 효능을 갖는 신규한 유산균 및 이의 용도
CA3086031C (en) Composition for contact dermatitis
Metzler-Zebeli et al. Ileal microbiota of growing pigs fed different dietary calcium phosphate levels and phytase content and subjected to ileal pectin infusion
CN111698913A (zh) 抑制脂肪蓄积用组合物
KR20190018204A (ko) 위액산 내성과 담즙산 내성이 탁월하고 높은 가바 생산성을 갖는 락토바실러스 브레비스 wcp02 균주, 이를 이용한 생균제제 및 발효식품
EP4209579A1 (en) Bifidobacterium inhibiting expression of muscle atrophy gene
JP4811760B2 (ja) ダイゼイン資化によるエコール生成能を改善するための腸内細菌およびその利用
CN105899090A (zh) 包含乳酸菌的肠道屏障功能促进剂
JP2023137059A (ja) 微生物、グルクロニダーゼ活性剤、プロバイオティクス組成物、食用組成物、及び更年期症状の予防又は治療用組成物
JP7828688B2 (ja) ブタ由来新規微生物
KR100443080B1 (ko) 콜레스테롤 저하능을 갖는 스트렙토코커스 페시움 균주
EP4599045A2 (en) Microbial strain compositions
Oyetayo Health importance of of faecal strain of Lactobacillus acidophilus used as probiotics in rats
Kieboomsa et al. Identification and characterisation of thiouracil forming
HK1229848B (en) Novel lactobacillus paracasei strain